Science Current Events | Science News | Brightsurf.com
 

Prostate Current Events | Prostate News

Sort By: Page Views | Date
Prostate specific antigen: A review of PSA use in screening for prostate cancer
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America.   view more (2007-06-19)

Annual prostate cancer screening test appears to save lives
Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings.   view more (2005-10-20)

PROSTATE CANCER SERIES (p 859)
A four-week series about prostate cancer-the third most common cancer in men worldwide, and the leading male cancer in Europe and North America-begins in this week's issue of THE LANCET. The first article, by Henrik Grönberg of Umea University, Sweden, assesses the epidemiology of prostate... view more (2003-03-05)

Prostate disease and fear of GPs
Men delay seeking help about symptoms of prostate disease because they believe GPs have negative attitudes toward them. Men also feel the available health information about prostate disease is `negative`. This is the finding of a study reported today, Friday 6 September 2002, at The British... view more (2002-09-02)

Low-risk prostate cancer patients face overtreatment
Many low-risk prostate cancer patients are being overtreated and might fare better if doctors monitored the cancer until treatment was necessary.   view more (2006-08-16)

PSA velocity's clinical usefulness remains unclear
Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool.   view more (2007-10-10)

MR imaging helps predict recurrence in prostate cancer patients
MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return.   view more (2007-05-07)

University of Kent Study Aims To Improve Information And Support Needs For Older Men With Prostate Cancer
The Centre for Health Services Studies (CHSS) at the University of Kent is currently engaged in an exploratory study of the information and support needs for men aged 75+ with prostate cancer.   view more (2004-11-03)

PSA test has higher accuracy for patients taking finasteride
Finasteride is a drug prescribed for men whose prostates have become enlarged. The drug decreases prostate swelling and helps men with urinary problems.   view more (2006-08-16)

Prostate Cancer Survival Benefit From A Combination Of Androgen Suppression And External Irradiation
Disease-free survival from advanced prostate cancer could be almost doubled if hormone-suppression therapy is used during and after radiotherapy for a duration of 3 years, suggest authors of an international study in this week's issue of THE LANCET. Long-term survival after radiotherapy for people... view more (2002-07-05)

3T MRI plays significant role in detecting prostate cancer, study says
The use of MRI without endorectal coil can detect prostate cancer and provide undistorted images with diagnostic image quality and accurate tumor localization, according to a recent study conducted by researchers from The Ohio State University in Columbus, OH.   view more (2008-04-14)

Prostate cancer spurs new nerves
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the... view more (2008-12-01)

Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.   view more (2008-01-02)

Men with prostate cancer want screening despite doubts over effectiveness of treatment
Most men with prostate cancer strongly advocate routine testing for prostate specific antigen (PSA), despite evidence that aggressive screening and treatment does not reduce deaths, according to two studies in this week's BMJ. In the first study, researchers at the University of Oxford interviewed... view more (2002-10-02)

New prostate cancer marker helps identify men whose cancer is likely to spread
Prostate cancer researchers at Sydney's Garvan Institute, supported by the Cancer Institute NSW, have found a new marker for identifying aggressive prostate cancers.   view more (2006-10-04)

Early warning: PSA testing can predict advanced prostate cancer
Researchers who showed that a single prostate specific antigen (PSA) test at age 50 or under could predict the presence of prostate cancer up to 25 years later, (regardless of clinical significance) have now found that a single PSA can be used to predict advanced prostate cancer.   view more (2008-02-15)

Research Probes Soy - Prostate Cancer Link
Researchers at the University of Ulster and Belfast City Hospital are set to launch a groundbreaking study that could offer a new insight into the prevention of prostate cancer. The study will focus on a significant link between low levels of serious prostate cancer and the presence of soy... view more (2002-07-30)

African-Americans with prostate cancer more likely to have family history of prostate, breast cancer
African-American men with prostate cancer were more likely to report a family history of prostate cancer and breast cancer among siblings than men who did not have prostate cancer, according to researchers at the University of Michigan Comprehensive Cancer Center.   view more (2006-12-04)

Popular Magazines Don't Inform Men About Prostate and Colon Cancer Screening
Decisions about screening for prostate and colon cancer require patients to have accurate, balanced information. Unfortunately, men are not getting this information from popular men's magazines. When articles are available, they often do not provide the information necessary for the reader to make... view more (2004-09-08)

Radiation seeds effectively cure prostate cancer in young men
Radiation seed implants (brachytherapy) are just as effective at curing prostate cancer in younger men (aged 60 and younger) as they are in older men.   view more (2007-10-30)

OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers.   view more (2008-06-02)

Hormone therapy before radiation seed implants for prostate cancer
Men over 70 years of age with early-stage prostate cancer have 20 percent higher mortality if they are treated first with hormone therapy before being treated with radiation seed implants (brachytherapy), compared to men who are treated with brachytherapy alone.   view more (2008-09-23)

FATTY FISH CONSUMPTION COULD REDUCE PROSTATE CANCER RISK
Consumption of fatty fish such as salmon, herring, and mackerel could reduce the risk of prostate cancer, report the authors of a research letter in this week's issue of THE LANCET. Essential fatty acids - especially omega-3 fatty acids contained in large amounts in fatty fish - have previously... view more (2001-05-31)

Prostate cancer patients see high survival rates with seed implants
More than ninety percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis.   view more (2007-02-01)

Urologist plays key role in determining use of hormone therapy in prostate cancer
The urologist a patient sees may be a more important factor than the tumor characteristics or the patient's other characteristics in determining the use of hormonal therapy for prostate cancer.   view more (2006-06-21)

Sort By: Page Views | Date
© 2008 BrightSurf.com